InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Pandite Arundathy N., Chief Medical Officer. Director active across 2 companies, notably Shattuck Labs, Inc.. Aggregated, 6 reports have been published. Total volume traded: €338k. The latest transaction was disclosed on 12 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
US$168,97530,000 shares@ US$5.63250.073% mcap100.0% of flow
Common Stock
SEC:0001193125-26-224669·
€168,97530,000 shares@ €5.63250.035% mcap100.0% of flow
Common Stock
SEC:0001193125-26-224669:0·
034,738 shares0
Common Stock
SEC:0000899243-22-001797·
034,738 shares0
Common Stock
SEC:0000899243-22-001797:0·
€364,259 shares@ €0.00850.0000% mcap100.0% of flow
Common Stock
SEC:0000899243-21-032549·
€364,259 shares@ €0.00850.0000% mcap0.0% of flow
Common Stock
SEC:0000899243-21-032549:0·
6 of 6 declarations
About Pandite Arundathy N.
Arundathy N. Pandite is the Chief Medical Officer at Shattuck Labs, Inc. She is responsible for the medical strategy and innovation within the company. Shattuck Labs focuses on developing advanced therapies. Arundathy plays a key role in guiding medical research and development initiatives.
